写给编辑的信:回复托普坎等人

Shengjin Dou1,2,3,4,5, Guopei Zhu1,2,3,4,5

  • 1Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

概括

对高风险的头腺状囊性癌 (ACC) 进行术后并发化疗 (CCRT) 并不建议进行例行治疗. 需要进行进一步的前性试验,以确认ACC患者的生存益处和管理治疗毒性.